Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequence.

Ahlers JD, Takeshita T, Pendleton CD, Berzofsky JA.

Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10856-61.

2.

Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa.

Cranage MP, Whatmore AM, Sharpe SA, Cook N, Polyanskaya N, Leech S, Smith JD, Rud EW, Dennis MJ, Hall GA.

Virology. 1997 Mar 3;229(1):143-54.

3.
4.
6.

HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women.

Musey L, Hu Y, Eckert L, Christensen M, Karchmer T, McElrath MJ.

J Exp Med. 1997 Jan 20;185(2):293-303.

9.
10.
11.

Novel approaches to peptide and engineered protein vaccines for HIV using defined epitopes: advances in 1994-1995.

Berzofsky JA, Berkower IJ.

AIDS. 1995;9 Suppl A:S143-57. Review. No abstract available.

PMID:
8819581
12.

Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes.

Klavinskis LS, Bergmeier LA, Gao L, Mitchell E, Ward RG, Layton G, Brookes R, Meyers NJ, Lehner T.

J Immunol. 1996 Sep 15;157(6):2521-7.

PMID:
8805653
13.

Antigen sampling across epithelial barriers and induction of mucosal immune responses.

Neutra MR, Pringault E, Kraehenbuhl JP.

Annu Rev Immunol. 1996;14:275-300. Review.

PMID:
8717516
14.
15.

Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques.

Lehner T, Wang Y, Cranage M, Bergmeier LA, Mitchell E, Tao L, Hall G, Dennis M, Cook N, Brookes R, Klavinskis L, Jones I, Doyle C, Ward R.

Nat Med. 1996 Jul;2(7):767-75.

PMID:
8673922
16.

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA.

Science. 1996 Jun 28;272(5270):1955-8.

PMID:
8658171
17.

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, Paxton WA.

Nature. 1996 Jun 20;381(6584):667-73.

PMID:
8649512
18.

Identification of a major co-receptor for primary isolates of HIV-1.

Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR.

Nature. 1996 Jun 20;381(6584):661-6.

PMID:
8649511
19.

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

Alexander-Miller MA, Leggatt GR, Berzofsky JA.

Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4102-7.

20.

HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.

Feng Y, Broder CC, Kennedy PE, Berger EA.

Science. 1996 May 10;272(5263):872-7.

PMID:
8629022
Items per page

Supplemental Content

Support Center